Instead, in subjects with T2DM the insulin secretion did not increase when compared with GLP-1 infusion alone, but there was an increase when compared with GIP and placebo administration, emphasizing the reduced insulinotropic effect of GIP in patients with diabetes. Here, INS is linked to diabetes mellitus.